Skip to main content

Interchange Capital Partners, LLC

Position in RXRX — Recursion Pharmaceuticals, Inc.

CIK 1845998 PITTSBURGH, PA

Position in RXRX

as of Jun 30, 2026 · filed Jul 20, 2026
Position Value
$49,321
-$22,713 QoQ
Shares Held
13,439
-42.7% QoQ
Ownership
0.003%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#236
of 340 holders
Holding Since
Dec 2023
11 quarters on record
Voting authority Sole 0% Shared 0% None 100%

Common Shares in RXRX Over Time

Shares Held

Position Value (USD)

Derivatives in RXRX

reported options exposure · as of Mar 31, 2026
CallValue
$1,842
CallShares
600
PutValue
$0
PutShares
0

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Interchange Capital Partners, LLC holds $548,470 across 3 Biotechnology names. RXRX ranks #3 (9.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
3 RXRX
Recursion Pharmaceuticals, Inc.
This page
13,439 $49,321

All Filings in RXRX

Export CSV
15 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $49,321 13,439
2026-03-31 $72,034 23,464
2026-03-31 $1,842 600
2025-12-31 $83,697 20,464
2025-09-30 $93,212 19,101
2025-06-30 $100,845 19,930
2025-03-31 $136,042 25,717
2025-03-31 $600 600
2024-12-31 $8,112 1,200
2024-12-31 $208,363 30,823
2024-09-30 $233,859 35,487
2024-09-30 $3,954 600
2024-06-30 $259,350 34,580
2024-03-31 $321,343 32,231
2023-12-31 $224,738 22,793